<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04041466</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A00721-56</org_study_id>
    <nct_id>NCT04041466</nct_id>
  </id_info>
  <brief_title>Validation Study of a Watch for the Detection of Atrial Fibrillation</brief_title>
  <acronym>MOVE-ECG</acronym>
  <official_title>Validation of the Watch Withings HWA08 for the Detection of Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Withings</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinact</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Withings</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed clinical study aims at validating the diagnostic performance, in comparison with
      a reference ECG, of Withings HWA08 watch for the automatic identification of atrial
      fibrillation (AF).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 7, 2019</start_date>
  <completion_date type="Actual">July 12, 2019</completion_date>
  <primary_completion_date type="Actual">July 12, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>AF and SR classification accuracy</measure>
    <time_frame>1 visit (30 minutes)</time_frame>
    <description>sensitivity and specificity of detection of AF and SR from 1-lead ECG against reference 12-lead ECG</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of the 1-lead ECG strips</measure>
    <time_frame>1 visit (30 minutes)</time_frame>
    <description>sensitivity and specificity of detection of AF and SR from 1-lead ECG strips reviewed by a blind, trained cardiologist against reference 12-lead ECG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>safety evaluation</measure>
    <time_frame>1 visit (30 minutes)</time_frame>
    <description>frequency of adverse events</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Arrythmia, Cardiac</condition>
  <arm_group>
    <arm_group_label>Atrial fibrillation (AF)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients diagnosed with AF during reference ECG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sinus Rhythm (SR)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients diagnosed with SR during reference ECG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other Arrythmia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients diagnosed with an arrhythmia other than AF during the reference ECG</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>AF detection by ECG</intervention_name>
    <description>Single-lead ECG with Withings watch HWA08 and reference 12-lead ECG</description>
    <arm_group_label>Atrial fibrillation (AF)</arm_group_label>
    <arm_group_label>Other Arrythmia</arm_group_label>
    <arm_group_label>Sinus Rhythm (SR)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults, men or women, at least 18 years old

          -  person having signed the informed consent form

          -  person affiliated to a social security system

        Exclusion Criteria:

          -  vulnerable subject according to current regulation:

               -  pregnant woman, parturient or breastfeeding

               -  subject deprived of freedom by judicial, medical or administrative decision

               -  subject legally protected or unable to express his consent

               -  subject non-beneficiary of healthcare

               -  subject falling into more than one of the above categories

          -  subject who refused to participate in the study

          -  subject in linguistic or psychic incapacity to sign a written informed consent form

          -  subject in physical incapacity to wear a watch on their wrist

          -  subject with electrical stimulation by pacemaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinique AXIUM Centre de cardiologie</name>
      <address>
        <city>Aix-en-Provence</city>
        <zip>13090</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Cardiologique du Nord</name>
      <address>
        <city>Saint-Denis</city>
        <zip>93200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 31, 2019</study_first_submitted>
  <study_first_submitted_qc>July 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2019</study_first_posted>
  <last_update_submitted>August 2, 2019</last_update_submitted>
  <last_update_submitted_qc>August 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Arrhythmias, Cardiac</keyword>
  <keyword>Cardiovascular diseases</keyword>
  <keyword>Heart diseases</keyword>
  <keyword>Wearable Electronic Devices</keyword>
  <keyword>Electrocardiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

